Clinical Trials Directory

Trials / Completed

CompletedNCT02941861

Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
67 (actual)
Sponsor
Ruechuta Molek · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Objective: 1. To study the factors that influence the 3- year recurrence of liver carcinoma after surgery 2. To study the related factors affecting recurrence of liver carcinoma after surgery

Detailed description

Liver carcinoma including 80% Hepatocellular carcinoma (HCC) and 20% Cholangiocarcinoma (CCA) becomes the leading causes of death in East and South-East Asia. Though hepatectomy is the treatment of choice for early stage cancer, the recurrence has been reported as 30%, 62% and 79% in 1st, 3rd and 5th year respectively. Chulabhorn hospital, a cancer institute established in 2011, has been performing a 3-years retrospective study on the influencing factors and its correlation to liver carcinoma after surgery.

Conditions

Interventions

TypeNameDescription
OTHERRecurrence Rate of HCC after surgeryRecurrence Rate of HCC after surgery
OTHERRecurrence Rate of CCA after surgeryRecurrence Rate of CCA after surgery

Timeline

Start date
2016-08-01
Primary completion
2016-08-01
Completion
2016-09-01
First posted
2016-10-21
Last updated
2016-10-21

Source: ClinicalTrials.gov record NCT02941861. Inclusion in this directory is not an endorsement.

Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery (NCT02941861) · Clinical Trials Directory